| pubmed-article:20693273 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20693273 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20693273 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20693273 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:20693273 | lifeskim:mentions | umls-concept:C0017710 | lld:lifeskim |
| pubmed-article:20693273 | lifeskim:mentions | umls-concept:C1705413 | lld:lifeskim |
| pubmed-article:20693273 | lifeskim:mentions | umls-concept:C0032893 | lld:lifeskim |
| pubmed-article:20693273 | lifeskim:mentions | umls-concept:C0034866 | lld:lifeskim |
| pubmed-article:20693273 | lifeskim:mentions | umls-concept:C0332173 | lld:lifeskim |
| pubmed-article:20693273 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:20693273 | pubmed:dateCreated | 2010-10-20 | lld:pubmed |
| pubmed-article:20693273 | pubmed:abstractText | To develop recommendations on monitoring for adverse events (AEs) of low-dose glucocorticoid (GC) therapy (?7.5 mg prednisone or equivalent daily) in clinical trials and daily practice. | lld:pubmed |
| pubmed-article:20693273 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20693273 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20693273 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20693273 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20693273 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20693273 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:20693273 | pubmed:issn | 1468-2060 | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:GuillevinLL | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:WebberSS | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:KirwanJ RJR | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:BoeroAA | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:AndrewsTT | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:CutoloMM | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:ButtgereitFF | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:WesthovensRR | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:RovenskyJJ | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:BijlsmaJ W... | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:JacobsJ W GJW | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:Da SilvaJ A... | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:CaeyersNN | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:Blom-BakkersM... | lld:pubmed |
| pubmed-article:20693273 | pubmed:author | pubmed-author:SeverijnsGG | lld:pubmed |
| pubmed-article:20693273 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20693273 | pubmed:volume | 69 | lld:pubmed |
| pubmed-article:20693273 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20693273 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20693273 | pubmed:pagination | 1913-9 | lld:pubmed |
| pubmed-article:20693273 | pubmed:meshHeading | pubmed-meshheading:20693273... | lld:pubmed |
| pubmed-article:20693273 | pubmed:meshHeading | pubmed-meshheading:20693273... | lld:pubmed |
| pubmed-article:20693273 | pubmed:meshHeading | pubmed-meshheading:20693273... | lld:pubmed |
| pubmed-article:20693273 | pubmed:meshHeading | pubmed-meshheading:20693273... | lld:pubmed |
| pubmed-article:20693273 | pubmed:meshHeading | pubmed-meshheading:20693273... | lld:pubmed |
| pubmed-article:20693273 | pubmed:meshHeading | pubmed-meshheading:20693273... | lld:pubmed |
| pubmed-article:20693273 | pubmed:meshHeading | pubmed-meshheading:20693273... | lld:pubmed |
| pubmed-article:20693273 | pubmed:meshHeading | pubmed-meshheading:20693273... | lld:pubmed |
| pubmed-article:20693273 | pubmed:meshHeading | pubmed-meshheading:20693273... | lld:pubmed |
| pubmed-article:20693273 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20693273 | pubmed:articleTitle | Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. | lld:pubmed |
| pubmed-article:20693273 | pubmed:affiliation | Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, The Netherlands. m.c.vandergoes@umcutrecht.nl | lld:pubmed |
| pubmed-article:20693273 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20693273 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20693273 | pubmed:publicationType | Consensus Development Conference | lld:pubmed |
